Kunduracı, M. S. Et Al. 2022. Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome. Seminars in Ophthalmology , vol.37, no.5 , 626-630.

Kunduracı, M. S., Kantarcı, B., Araz Erşan, H. B., & Tuğcu, B., (2022). Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome. Seminars in Ophthalmology , vol.37, no.5, 626-630.

Kunduracı, Merve Et Al. "Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome," Seminars in Ophthalmology , vol.37, no.5, 626-630, 2022

Kunduracı, Merve S. Et Al. "Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome." Seminars in Ophthalmology , vol.37, no.5, pp.626-630, 2022

Kunduracı, M. S. Et Al. (2022) . "Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome." Seminars in Ophthalmology , vol.37, no.5, pp.626-630.

@article{article, author={Merve Sena Kunduracı Et Al. }, title={Use of Botulinum Toxin A in the Treatment of Intermittent Exotropia: Factors Affecting Treatment Outcome}, journal={Seminars in Ophthalmology}, year=2022, pages={626-630} }